Leucocytoclastic vasculitis-like reaction induced by tocilizumab in a patient with rheumatoid arthritis

被引：3
作者：
Hu, Yu-Qing [1 ]
Chen, Xue [1 ]
Zhang, Jian-Zhong [1 ]
机构：
[1] Peking Univ Peoples Hosp, Dept Dermatol, Beijing, Peoples R China
来源：
DERMATOLOGIC THERAPY | 2022年 / 35卷 / 12期
基金：
中国国家自然科学基金;
关键词：
IL-6; RECEPTOR;
D O I：
10.1111/dth.15944
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页数：2
相关论文
共 9 条
[1]   Does tocilizumab have a role in dermatology? A review of clinical applications, its adverse side effects and practical considerations [J].
Choong, Dean Jeremy ;
Tan, Ernest .
DERMATOLOGIC THERAPY, 2021, 34 (04)
[2]   Anti-TNF-Related Leukocytoclastic Vasculitis in Ulcerative Colitis: A Case Report [J].
Giorgio, Valentina ;
Blasi, Elisa ;
Rigante, Donato ;
Guerriero, Cristina ;
De Simone, Clara ;
Fedele, Anna Laura ;
Stella, Giuseppe ;
Gasbarrini, Antonio ;
Scaldaferri, Franco .
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (13)
[3]   Apixaban-induced cutaneous leucocytoclastic vasculitis [J].
Khan, Munim ;
Madi, Mahmoud Y. ;
Rencic, Joseph .
BMJ CASE REPORTS, 2020, 13 (08)
[4]   Tocilizumab-induced pustular drug eruption [J].
Mori, Tatsuhiko ;
Yamamoto, Toshiyuki .
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2017, 20 (11) :1776-1777
[5]   Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease [J].
Nishimoto, Norihiro ;
Terao, Kimio ;
Mima, Toru ;
Nakahara, Hideko ;
Takagi, Nobuhiro ;
Kakehi, Takahiro .
BLOOD, 2008, 112 (10) :3959-3964
[6]   Tocilizumab-Induced Psoriasiform Rash in Rheumatoid Arthritis [J].
Palmou-Fontana, Natalia ;
Sanchez Gavino, Juan Antonio ;
McGonagle, Dennis ;
Garcia-Martinez, Eva ;
de Onzono Martin, Luis Iniguez .
DERMATOLOGY, 2014, 228 (04) :311-313
[7]   Tocilizumab-induced leucocytoclastic vasculitis in a patient with rheumatoid arthritis [J].
Sakaue, Saori ;
Sumitomo, Shuji ;
Kubo, Kanae ;
Fujio, Keishi ;
Yamamoto, Kazuhiko .
RHEUMATOLOGY, 2014, 53 (08) :1529-1530
[8]   The continuing evolution of targeted therapy for inflammatory skin disease [J].
Schlapbach, C. ;
Navarini, A. A. .
SEMINARS IN IMMUNOPATHOLOGY, 2016, 38 (01) :123-133
[9]   Drug eruption induced by IL-6 receptor inhibitor tocilizumab [J].
Yoshiki, R. ;
Nakamura, M. ;
Tokura, Y. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2010, 24 (04) :495-496
1